Aberdeen Group
BHVN icon

Aberdeen Group’s Biohaven BHVN Stock Holding History

Aberdeen Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44M Sell
365,519
-405,933
-53% -$4.37M 0.01% 687
2026
Q1 		$6.53M Buy
771,452
+78,000
+11% +$853K 0.01% 665
2025
Q4 		$7.83M Buy
+693,452
New +$8.59M 0.01% 649

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aberdeen Group's BHVN Position: Q2 2026 in Review

Aberdeen Group reduced its Biohaven (BHVN) stake by 53% in Q2 2026, selling an estimated $4.37M and leaving 365,519 shares worth $5.44M. The position accounts for 0.01% of the portfolio, ranked #687.

Aberdeen Group first reported a position in BHVN in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.83M in Q4 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Aberdeen Group held 365,519 shares of Biohaven worth $5.44M as of Q2 2026.
  • Aberdeen Group sold 405,933 Biohaven shares in Q2 2026, an estimated $4.37M.
  • Biohaven made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #687 holding.
  • Aberdeen Group first reported a position in Biohaven in Q4 2025 and has held it in 3 quarters since.
  • Aberdeen Group's Biohaven position peaked at $7.83M in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.